Crossref
22 Disparities in Non-Melanoma Skin Cancer Survival Among Patients with Immune-Mediated Inflammatory Diseases: A Population-Based Study
Journal of Investigative Dermatology · 2025-11 · 145 (11) · e35
DOI: 10.1016/j.jid.2025.09.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Ahmed Almezaine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Almezaine, A. (2025). 22 Disparities in Non-Melanoma Skin Cancer Survival Among Patients with Immune-Mediated Inflammatory Diseases: A Population-Based Study. Journal of Investigative Dermatology, 145(11), e35. https://doi.org/10.1016/j.jid.2025.09.042
Vancouver
Almezaine A. 22 Disparities in Non-Melanoma Skin Cancer Survival Among Patients with Immune-Mediated Inflammatory Diseases: A Population-Based Study. Journal of Investigative Dermatology. 2025;145(11):e35. doi:10.1016/j.jid.2025.09.042
BibTeX
@article{Almezaine2025,
author = {Almezaine, Ahmed},
title = {22 Disparities in Non-Melanoma Skin Cancer Survival Among Patients with Immune-Mediated Inflammatory Diseases: A Population-Based Study},
journal = {Journal of Investigative Dermatology},
year = {2025},
volume = {145},
number = {11},
pages = {e35},
doi = {10.1016/j.jid.2025.09.042}
}
EUVIMED